Karola Vorauer-Uhl is an Associate Professor at the Institute of Biochemical Engineering, Department of Biotechnology and Food Sciences, University of Natural Resources and Life Sciences, Vienna (BOKU). She is based at Muthgasse 18, Vienna, and holds a doctorate in life sciences and biotechnology. Her work is deeply rooted in biopharmaceutical technology, particularly in liposomal drug delivery and recombinant protein production. Her research interests center on advanced bioprocess technologies. She specializes in liposomal formulations for therapeutic and vaccine delivery, with a focus on protein encapsulation and liposome-protein interactions. A key methodological expertise is bio-layer interferometry (BLI) , which she uses for real-time, label-free analysis of molecular binding. Her work also encompasses CHO cell culture processes , quality by design (QbD) , process analytical technology (PAT) , and the development of recombinant proteins like erythropoietin and HIV envelope proteins for biomedical applications. The 15 most recent publications highlight a consistent research trajectory in biopharmaceutical process development and nanoparticle-based delivery systems . Early works focused on protein purification and liposome production, while recent contributions emphasize advanced analytical methods like BLI for characterizing protein-liposome interactions and implementing QbD/PAT in mammalian cell cultures. The dominant themes are liposome technology , protein characterization , and bioprocess optimization , with applications in drug and vaccine delivery. ao.Univ.Prof. (Associate Professor), BOKU Vienna Habilitation in Biopharmaceutical Technology, 2002 Promotion (PhD) in Food and Biotechnology, 1993 Dipl.-Ing. in Food and Biotechnology, 1988 Karola Vorauer-Uhl has made significant contributions to the development of liposomal therapeutics and vaccines. Her work on GMP-compliant liposome production and novel techniques like the cross-flow injection method demonstrates a strong focus on translating research into industrial applications. She has been involved in projects related to HIV vaccine development using virosomes and the therapeutic use of liposomal superoxide dismutase. Her community service includes participation in numerous scientific conferences and workshops, particularly in the fields of bioprocessing and liposome research. She is actively engaged in academic advising, as evidenced by her supervision of university theses. Her laboratory or research group appears to focus on bioprocess engineering, with expertise in recombinant protein expression, liposome formulation, and advanced analytical characterization. Collaborations with industry partners and other research institutions, especially in the area of biopharmaceuticals, are a consistent feature of her work.